This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2020.
Company Filing History:
1 out of 1,265 
1 out of 482 
Years Active: 2020
Title: Channing Yu: Innovator in Cancer Cell Assays
Introduction
Channing Yu is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cancer research. His innovative work focuses on developing methods to assay mixed cell populations, which is crucial for understanding the complexities of cancer.
Latest Patents
Channing Yu holds a patent for "Multiplex methods to assay mixed cell populations simultaneously." This patent describes methods to simultaneously test and screen multiplexed, mixed cell populations, particularly those comprising genetically heterogeneous cancer cells, under common conditions. His work in this area is vital for advancing cancer diagnostics and treatment strategies.
Career Highlights
Throughout his career, Channing Yu has worked with prestigious organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute. His experience in these leading research institutions has allowed him to contribute to groundbreaking advancements in cancer research.
Collaborations
Channing Yu has collaborated with notable professionals in his field, including Todd R. Golub, enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Channing Yu's contributions to cancer research through his patented methods and collaborations with leading institutions highlight his role as an important innovator in the field. His work continues to pave the way for advancements in cancer diagnostics and treatment.